Start-Up Quarterly Statistics, Q1 2015

22 May 2015

• By Deanna Kamienski

In Q1 2015 start-ups raised $2.74 billion, a new record. Biopharma companies penned 37 alliances; 13 start-ups were acquired across all industries.

During the first quarter of 2015, start-up companies raised a total of $2.74 billion, the third quarter in a row in which the record has been broken. (Last quarter’s total was $1.46 billion.) Biopharma companies pulled in an impressive $2.32 billion, half resulting from public start-up fundraising (PIPEs, IPOs, follow-ons). Medical device firms raised $72.5 million (77% from an IPO), and in vitro diagnostics companies combined for $350.4 million, nearly one-third also the result of a start-up going public. (See Exhibit 1.)

Exhibit 1

Deal Watch: Novartis Hopes To Ace Inflammatory Disease With Matchpoint Tie-Up

25 Jul 2025

• By Joseph Haas, Lisa Takagi, and Manas Mishra

Plus deals involving Lilly/Gate Bioscience, Concentra/iTeos, Nicox/Kowa, Ajax/Schrodinger, I-Mab/Bridge Health, Otsuka/Cantargia, JCR/Acumen and more.

Gateway To Africa: Natco Bids For 35.75% Of Adcock Ingram

24 Jul 2025

• By Anju Ghangurde

Natco to buy out Adcock Ingram’s minority shareholders in what’s possibly its biggest M&A investment, opening up substantial opportunities in South Africa and the region. If the offer goes through, it will result in the delisting of Adcock, with Bidvest and Natco co-owning the firm.

Scrip M&A Podcast: Is Biopharma M&A In A Holding Pattern Or A ‘New Normal’

23 Jul 2025

• By Joseph Haas

Scrip discusses the latest M&A activity and trends with CEO Shawn Titcomb of Allele Capital and Cheryl Reicin, a partner focused on international life sciences activity at Mintz.